Approval · Notice of Compliance 35462 · 2025
PLAN B: Notice of Compliance 35462
Issued June 3, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35462
- Date
- June 3, 2025
- Company
- Foundation Consumer Healthcare, LlcPittsburgh, Pennsylvania, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to package labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLAN B | 02293854 | Marketed |
Medicinal ingredients
- LEVONORGESTREL 1.5 MG per TAB